BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Press Releases

  Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies

  September 29, 2026

   · 

  6 min read
• 

  China

  Novo adds long-term obesity differentiation in up to $2.6B Hengrui deal

  Investors looking for more transformative business development at Novo will have to wait, but a new partnership with China’s Hengrui Pharma adds a new weekly oral option to the Danish pharma’s early pipeline.

  September 29, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  Telitacicept Demonstrates Deep and Durable Minimal Symptom Expression Through 48 Weeks in Generalized Myasthenia Gravis

  September 29, 2026

   · 

  7 min read
• Press Releases

  argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

  September 29, 2026

   · 

  23 min read
• Press Releases

  Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda

  September 29, 2026

   · 

  4 min read
• Press Releases

  Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting

  September 29, 2026

   · 

  7 min read
• Press Releases

  Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron

  September 29, 2026

   · 

  4 min read
• Press Releases

  Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD

  September 29, 2026

   · 

  16 min read
• Press Releases

  Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

  September 29, 2026

   · 

  8 min read
• Press Releases

  NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

  September 29, 2026

   · 

  9 min read